• 1
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcomes in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 2
    Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ 2001; 322: 135760.
  • 3
    Tennant A. Quality of life—a measure too far? Ann Rheum Dis 1995; 54: 43940.
  • 4
    Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997; 278: 4750.
  • 5
    Kuyken W, Group TW. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 14039.
  • 6
    Power M, Harper A, Bullinger M. The World Health Organization WHOQOL-100: tests of the universality of quality of life in 15 different cultural groups worldwide. Health Psychol 1999; 18: 495505.
  • 7
    Harper H, Power M, Group TW. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 5518.
  • 8
    Bekkelund SI, Husby G, Mellgren SI. Quality of life in rheumatoid arthritis: a case-control study in patients living in northern Norway. Clin Exp Rheumatol 1995; 13: 4715.
  • 9
    de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997; 36: 87883.
  • 10
    Ortiz Z, Shea B, Garcia Dieguez M, Boers M, Tugwell P, Boonen A, et al. The responsiveness of generic quality of life instruments in rheumatic diseases: a systematic review of randomized controlled trials. J Rheumatol 1999; 26: 2106.
  • 11
    Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003; 56: 5260.
  • 12
    Wirnsberger RM, De Vries J, Jansen TL, Van Heck GL, Wouters EF, Drent M. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med 1999; 54: 8695.
  • 13
    Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982; 9: 78993.
  • 14
    Raphael D, Brown I, Renwick R, Cava M, Weir N, Heathcote K. The quality of life of seniors living in the community: a conceptualization with implications for public health practice. Can J Public Health 1995; 86: 22833.
  • 15
    Meng XL, Rosenthal R, Rubin DB. Comparing correlated correlation coefficients. Psychol Bull; 111: 1725.
  • 16
    Burnand B, Kernan WN, Feinstein AR. Indexes and boundaries for “quantitative significance” in statistical decisions. J Clin Epidemiol 1990; 43: 127384.
  • 17
    Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chron Dis 1986; 39: 897906.
  • 18
    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a non-parametric approach. Biometrics 1988; 44: 83745.
  • 19
    Scott DL, Strand V. The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score: lessons from the leflunomide clinical trials database. Rheumatology 2002; 41: 899909.
  • 20
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials: the Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 72940.
  • 21
    Murphy B, Herrman H, Hawthorne G, Pinzone T, Evert H. Australian WHOQoL instruments: user's manual and interpretation guide. Melbourne, Australia: Australian WHOQoL Field Study Centre; 2000.
  • 22
    Hawthorne G, Richardson J, Day N, Osborne R, McNeil H. Construction and utility scaling of the Assessment of Quality of Life (AQoL) instrument. Melbourne, Australia: Centre for Health Program Evaluation; 2000.
  • 23
    Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
  • 24
    Fayers PM, Machin D. Factor analysis. In: Staquet MJ, Hays RD, Fayers PM, editors. Quality of life assessment in clinical trials: methods and practice. New York: Oxford University Press; 1998.
  • 25
    Yao G, Chung CW, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc 2002; 101: 34251.
  • 26
    Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol 1997; 50: 86979.
  • 27
    O'Carroll RE, Smith K, Couston M, Cossar JA, Hayes PC. A comparison of the WHOQOL-100 and the WHOQOL-BREF in detecting change in quality of life following liver transplantation. Qual Life Res 2000; 9: 1214.
  • 28
    Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27(3 Suppl ): S21732.
  • 29
    Damiano AM, Steinberg EP, Cassard SD, Bass EB, Diener-West M, Legro MW, et al. Comparison of generic versus disease-specific measures of functional impairment in patients with cataract. Med Care 1995; 33(4 Suppl ): AS12030.
  • 30
    Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985; 28: 5427.
  • 31
    Verhoeven AC, Boers M, van der Linden S. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis. Ann Rheum Dis 2000; 59: 96674.
  • 32
    Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992; 30: 91725.
  • 33
    Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28: 63242.
  • 34
    Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, et al, Leflunomide Rheumatoid Arthritis Investigators Group. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Arthritis Rheum 2000; 43: 50614.
  • 35
    Eberhardt K, Duckberg S, Larsson BM, Johnson PM, Nived K. Measuring health related quality of life in patients with rheumatoid arthritis: reliability, validity, and responsiveness of a Swedish version of RAQoL. Scan J Rheumatol 2002; 31: 612.
  • 36
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 2936.